VBI Vaccines, Inc. – (VBIV) Sees Large Volume Increase
VBI Vaccines, Inc. – (NASDAQ:VBIV) shares saw unusually-high trading volume on Tuesday . Approximately 63,803 shares changed hands during mid-day trading, an increase of 4% from the previous session’s volume of 61,207 shares.The stock last traded at $3.93 and had previously closed at $3.85.
The firm’s market capitalization is $126.21 million. The firm has a 50-day moving average of $4.00 and a 200-day moving average of $4.01.
An institutional investor recently bought a new position in VBI Vaccines, Inc. – stock. Cambridge Investment Research Advisors Inc. acquired a new stake in shares of VBI Vaccines, Inc. – (NASDAQ:VBIV) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,433,100 shares of the biopharmaceutical company’s stock, valued at approximately $3,497,000. Cambridge Investment Research Advisors Inc. owned 6.09% of VBI Vaccines, Inc. – as of its most recent filing with the SEC.
VBI Vaccines Inc, formerly SciVac Therapeutics Inc, is a biotechnology company. The Company is engaged in developing various technologies that focus on vaccine protection. It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines. It is involved in various projects related to human cytomegalovirus (CMV) and other antigens.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.